tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Taylor Feehley, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst Taylor Feehley, carries an average stock price target met ratio of 50% that have a potential upside of 13.09% achieved within 19 days.
Taylor Feehley’s has documented 7 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SYBX, Synlogic at 30-Mar-2023.
Analyst best performing recommendations are on MCRB (SERES THERAPEUTICS).
The best stock recommendation documented was for MCRB (SERES THERAPEUTICS) at 9/18/2020. The price target of $560 was fulfilled within 11 days with a profit of $47 (9.16%) receiving and performance score of 8.33.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$5
1 years 11 months ago
(09-Feb-2024)
6/6 (100%)
$-2.65 (-34.64%)
96
Hold
Since 09-Feb-2024
$1
$-0.17 (-14.53%)
$8
1 years 11 months ago
(09-Feb-2024)
4/5 (80%)
$-0.77 (-43.50%)
404
Hold
Since 09-Feb-2024
1 years 11 months ago
(09-Feb-2024)
0/1 (0%)
$94.35 (169.54%)
Buy
Since 13-Dec-2018
$300
2 years 9 months 10 days ago
(30-Mar-2023)
0/1 (0%)
$186.9 (165.25%)
Buy
Since 24-Nov-2021
3 years 2 months 22 days ago
(18-Oct-2022)
0/1 (0%)
$127.05 (88.88%)
What Year was the first public recommendation made by Taylor Feehley?
